Discover 585 paid clinical trials in Richmond, Virginia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 585
Neoadjuvant Zanzalintinib Plus Nivolumab in Patients With Locally Advanced and/or Inoperable Clear Cell Renal Cell Carcinoma With or Without Non-measurable Metastasis
for
Locally Advanced Renal Cell Carcinoma
Location: Richmond VA, St Louis MO, Dallas TX
Sponsor: Qian Qin
Sex: All
Age: 18+
Code: NCT06794229
Phase 2, Recruiting
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
for
Advanced Or Metastatic Merkel Cell Carcinoma
Location: Richmond VA, Fairfax VA, Greenville NC, Morgantown WV,
Sponsor: TuHURA Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT06947928
Phase 2, Phase 3, Recruiting
Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Extension
for
DM1, Myotonic Dystrophy, Myotonic Dystrophy 1,
Location: Richmond VA
Sponsor: Virginia Commonwealth University
Sex: All
Age: 18 - 70
Code: NCT07700225
Recruiting
Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
for
Heart Failure With Reduced Ejection Fraction (HFrEF),
Location: Richmond VA, Brooklyn NY, Rochester NY, Detroit MI,
Sponsor: University of Rochester
Sex: All
Age: 18+
Code: NCT06964464
Recruiting
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
for
Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Location: Richmond VA, Hawthorne NY, Columbus OH, Lexington KY,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07063745
Phase 2, Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis